Severson J A, Finch C E
Brain Res. 1980 Jun 16;192(1):147-62. doi: 10.1016/0006-8993(80)91015-x.
[3H]Spiroperidol and [3H]ADTN ( 2-amino-l,7-dihydroxy-1,2,3,4-tetra hydronaphthalene) binding were used to assay for dopamine receptors in aged C57BL/6J mouse striatal membranes. [3H]spiroperidol binding declined linearly with age starting at 3 months. By 28 months, spiroperidol binding was only about 50% of the 3 month value. Dissociation constants dissociation rates and binding inhibition by (+)-butaclamol (antagonist) and apomorphine (agonist) were similar, suggesting that the age-related loss of spiroperidol binding was due to a loss in receptor number and not an alteration in binding affinity. [3H]ADTN binding also declined with age, but the losses tended to be about twice as large as those seen for spiroperidol. Consideration of possible mechanisms of receptor loss with age indicate that nigrostriatal denervation effects cannot explain all aging changes in striatal dopaminergic functions. The loss of receptors with age may derive from a loss of striatal neurones on which residue a population of dopaminergic binding sites.
采用[3H]螺哌啶醇和[3H]ADTN(2-氨基-1,7-二羟基-1,2,3,4-四氢萘)结合法检测老年C57BL/6J小鼠纹状体膜中的多巴胺受体。[3H]螺哌啶醇结合量从3个月开始随年龄呈线性下降。到28个月时,螺哌啶醇结合量仅为3个月时的约50%。解离常数、解离速率以及(+)-布他拉莫(拮抗剂)和阿扑吗啡(激动剂)的结合抑制作用相似,这表明与年龄相关的螺哌啶醇结合量减少是由于受体数量减少而非结合亲和力改变所致。[3H]ADTN结合量也随年龄下降,但减少幅度往往是螺哌啶醇的两倍左右。对受体随年龄减少的可能机制的研究表明,黑质纹状体去神经支配效应无法解释纹状体多巴胺能功能的所有衰老变化。受体随年龄减少可能源于纹状体神经元的丧失,而多巴胺能结合位点就位于这些神经元上。